Merck’s Enflonsia (clesrovimab) has been approved by the European Commission for the prevention of respiratory syncytial ...
AstraZeneca has reported positive high-level results from the phase 3 MIRANDA trial of tozorakimab, showing a statistically ...
Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...
Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...
Johnson & Johnson’s (J&J) Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and paediatric patients. Icotyde, an interleukin-23 ...
Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in ...
AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects ...
Launching a new therapy is an uphill battle for emerging biopharma, with limited budgets and human resources. Yet in 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results